Making full use of big data and in-house molecular pathology technology, we were the first group to measure the clinicopathological significance of CKS2 in pooled multi-center endometrial carcinoma samples and to investigate the molecular basis of CKS2 in endometrial carcinoma through upstream transcriptional analysis, immune correlation analysis, and co-expression analysis. Here, CKS2 is linked to endometrial carcinoma.